BioPorto A/S (CPH:BIOPOR)

BioPorto Revenue

BioPorto had revenue of 6.90M DKK in the quarter ending June 30, 2026, a decrease of -34.83%. This brings the company's total for the last twelve months to 38.37M, up 7.06% year-over-year. In the year 2025, BioPorto had annual revenue of 40.29M with 11.16% growth. That makes BioPorto the 39,521st largest company in the world by revenue and 113th in Denmark.

• Revenue (ttm): 38.37M
• Revenue Growth: +7.06%
• P/S Ratio: 12.88
• Revenue / Employee: 872.02K
• Employees: 44
• Market Cap: 494.12M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• NGAL Tests 28.22M 70.1%
• Antibodies 10.54M 26.1%
• ELISA Kits 1.38M 3.4%
• Royalty and Other 148.00K 0.4%

By Geography

Chart

• North America 24.18M 60.0%
• Denmark, and Rest of Europe 12.23M 30.3%
• Asia 3.88M 9.6%

Fiscal year ended Dec 31, 2025 See the full BioPorto breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	40.29M	4.04M	11.16%
Dec 31, 2024	36.24M	5.29M	17.07%
Dec 31, 2023	30.96M	1.99M	6.87%
Dec 31, 2022	28.97M	4.72M	19.44%
Dec 31, 2021	24.25M	1.05M	4.53%
Dec 31, 2020	23.20M	-3.42M	-12.84%
Dec 31, 2019	26.62M	606.00K	2.33%
Dec 31, 2018	26.02M	861.00K	3.42%
Dec 31, 2017	25.16M	4.44M	21.40%
Dec 31, 2016	20.72M	337.00K	1.65%
Dec 31, 2015	20.38M	1.68M	8.97%
Dec 31, 2014	18.71M	2.08M	12.51%
Dec 31, 2013	16.63M	-1.23M	-6.90%
Dec 31, 2012	17.86M	-726.00K	-3.91%
Dec 31, 2011	18.58M	4.78M	34.65%
Dec 31, 2010	13.80M	2.79M	25.38%
Dec 31, 2009	11.01M	1.13M	11.47%
Dec 31, 2008	9.88M	1.54M	18.41%
Dec 31, 2007	8.34M	2.79M	50.16%
Dec 31, 2006	5.55M	1.19M	27.33%
Dec 31, 2005	4.36M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 20, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error